Jiangsu Alpha Pharmaceutical Co., Ltd.

Products

tert-butyl 2-((4R,6R)-6-(2-aminoethyl)-2,2-dimethyl-1,3-dioxan-4-yl) acetate

    • Product Name: tert-butyl 2-((4R,6R)-6-(2-aminoethyl)-2,2-dimethyl-1,3-dioxan-4-yl) acetate
    • Chemical Name (IUPAC): tert-butyl 2-[(4R,6R)-6-(2-aminoethyl)-2,2-dimethyl-1,3-dioxan-4-yl]acetate
    • CAS No.: 1416992-39-4
    • Chemical Formula: C14H27NO5
    • Form/Physical State: Oil
    • Factroy Site: Yinchuan, Ningxia, China
    • Price Inquiry: sales8@bouling-chem.com
    • Manufacturer: Jiangsu Alpha Pharmaceutical Co., Ltd.
    • CONTACT NOW
    VTB
    Specifications
    HS Code 256535
    Iupac Name tert-butyl 2-((4R,6R)-6-(2-aminoethyl)-2,2-dimethyl-1,3-dioxan-4-yl)acetate
    Molecular Formula C14H27NO5
    Cas Number 1219808-16-8
    Appearance Colorless to pale yellow oil
    Purity Typically >98%
    Solubility Soluble in organic solvents such as DMSO, methanol
    Smiles CC(C)(C)OC(=O)CC1C(COCC1(C)C)CCN
    Storage Conditions Store at -20°C, protected from light and moisture
    Optical Activity (4R,6R) stereochemistry
    Functional Groups Ester, tertiary butyl, aminoethyl, acetal (1,3-dioxane)

    As an accredited tert-butyl 2-((4R,6R)-6-(2-aminoethyl)-2,2-dimethyl-1,3-dioxan-4-yl) acetate factory, we enforce strict quality protocols—every batch undergoes rigorous testing to ensure consistent efficacy and safety standards.

    Packing & Storage
    Packing 50 g of tert-butyl 2-((4R,6R)-6-(2-aminoethyl)-2,2-dimethyl-1,3-dioxan-4-yl) acetate in a sealed amber glass bottle.
    Container Loading (20′ FCL) Container loading (20′ FCL) for tert-butyl 2-((4R,6R)-6-(2-aminoethyl)-2,2-dimethyl-1,3-dioxan-4-yl) acetate ensures secure, efficient bulk chemical transport.
    Shipping The shipping of tert-butyl 2-((4R,6R)-6-(2-aminoethyl)-2,2-dimethyl-1,3-dioxan-4-yl)acetate requires secure, airtight packaging under temperature-controlled conditions, typically ambient unless specified otherwise. It must comply with relevant chemical shipping regulations, including labeling and documentation. Avoid exposure to moisture and direct sunlight. Handle with appropriate personal protective equipment during transport and handling.
    Storage Store tert-butyl 2-((4R,6R)-6-(2-aminoethyl)-2,2-dimethyl-1,3-dioxan-4-yl) acetate in a tightly sealed container, protected from light and moisture, at 2–8 °C (refrigerator). Keep away from incompatible substances such as strong acids and oxidizers. Ensure storage in a well-ventilated, dry area, and follow all relevant safety protocols for handling amines and esters.
    Shelf Life Shelf life: Store at -20°C, protected from light and moisture; stable for at least 2 years under recommended conditions.
    Application of tert-butyl 2-((4R,6R)-6-(2-aminoethyl)-2,2-dimethyl-1,3-dioxan-4-yl) acetate

    Applications of tert-butyl 2-((4R,6R)-6-(2-aminoethyl)-2,2-dimethyl-1,3-dioxan-4-yl) acetate in Industrial Manufacturing

    tert-butyl 2-((4R,6R)-6-(2-aminoethyl)-2,2-dimethyl-1,3-dioxan-4-yl) acetate functions as a specialized intermediate for advanced chemical synthesis, addressing the high standards required by pharmaceutical, agrochemical, and fine chemical industries. We support global B2B partners with batch-to-batch consistency and tailored technical documentation throughout each downstream scenario.

    1. API Intermediate for Antihypertensive Drugs

    This compound serves as a chiral building block in the multi-step manufacturing of antihypertensive active pharmaceutical ingredients, particularly those utilizing the dioxane ring for enhanced molecular stability and selectivity. Pharmaceutical synthesis lines incorporate this intermediate during the late-stage reaction step, facilitating coupling, protection-deprotection, and final API refinement. Our batches maintain low residual solvents and high optical purity to ensure downstream compliance with global markets.

    Industry compliance standards

    Typical usage ratio

    Downstream process integration

    Final product types

    2. Chiral Selector Component in Preparative Chromatography Media

    Downstream producers utilize this specialty acetate as a precursor for immobilizing chiral selectors onto silica and polymeric chromatography resins. It enables the resolution of racemic drug substances at pilot and production scales. Our production controls focus on limiting ionic and fluorescent impurities that interfere with preparative detection and loading parameters within process-scale chromatography columns.

    Industry compliance standards

    Typical usage ratio

    Downstream process integration

    Final product types

    3. Protected Amine Intermediate for Peptide Synthesis

    Peptide manufacturing lines apply this material as a protected amine intermediate, improving synthesis yields for complex therapeutic peptides with challenging sequences. Its dioxane-protected form allows extended reaction times without side-chain loss or undesired cyclization. In downstream processes, it reliably undergoes deprotection under mild acidic conditions before final peptide chain coupling.

    Industry compliance standards

    Typical usage ratio

    Downstream process integration

    Final product types

    4. Building Block for Selective Agrochemical Synthesis

    Agrochemical manufacturers include this acetate derivative as a key intermediate within multi-step flow chemistry for producing next-generation selective herbicides and insecticides where chiral control is crucial for regulatory approval and field performance. Our strict impurity profiling supports downstream compliance with residue limit standards for global agricultural use.

    Industry compliance standards

    Typical usage ratio

    Downstream process integration

    Final product types

    5. Specialty Monomer in Medical Polymer Synthesis

    Medical polymer processers adopt this chemical as a specialty monomer for introducing pendant amine and acetal functionalities into resorbable scaffolds and hydrogels. These scaffolds require precise control of degradation and bioactivity for use in controlled drug release devices. Our in-process sampling and documentation allow traceable batch quality for critical material release.

    Industry compliance standards

    Typical usage ratio

    Downstream process integration

    Final product types

    6. Fine Chemical Intermediate for Optical Brightener Synthesis

    Fine chemical companies employ this acetate as an amine-functionalized scaffold in the synthesis routes of certain optical brighteners, particularly those based on dioxane substructures for improved UV absorption and chemical resistance. The material undergoes selective activation, followed by diversification with aromatic groups to achieve desired absorption spectra. Our controlled trace metal and aldehyde levels support downstream product qualification for sensitive industrial requirements.

    Industry compliance standards

    Typical usage ratio

    Downstream process integration

    Final product types

    Free Quote

    Competitive tert-butyl 2-((4R,6R)-6-(2-aminoethyl)-2,2-dimethyl-1,3-dioxan-4-yl) acetate prices that fit your budget—flexible terms and customized quotes for every order.

    For samples, pricing, or more information, please contact us at +8618005193850 or mail to sales8@bouling-chem.com.

    We will respond to you as soon as possible.

    Tel: +8618005193850

    Email: sales8@bouling-chem.com

    Inquiry

    Get Free Quote of Jiangsu Alpha Pharmaceutical Co., Ltd.

    Flexible payment, competitive price, premium service - Inquire now!

    Certification & Compliance
    More Introduction

    tert-butyl 2-((4R,6R)-6-(2-aminoethyl)-2,2-dimethyl-1,3-dioxan-4-yl) acetate: A Manufacturer’s Perspective

    Insights into Our Work With tert-butyl 2-((4R,6R)-6-(2-aminoethyl)-2,2-dimethyl-1,3-dioxan-4-yl) acetate

    Over years of synthetic chemistry development, our team has worked with a wide range of chiral building blocks for small molecule drug candidates and bioactive intermediates. tert-butyl 2-((4R,6R)-6-(2-aminoethyl)-2,2-dimethyl-1,3-dioxan-4-yl) acetate has stood out among these, not just for its complexity, but for the reliability it offers across diverse research programs. Our chemists remember the first multigram synthesis campaign in our pilot labs: a complex orchestration of protection, chiral resolution, and precise isolation steps, demanding fine attention to temperature and moisture. Our focus then and now remains quality that yields reproducible results in the hands of those driving innovation in both academic and commercial settings.

    The molecule features a tert-butyl-protected acetate group, a dioxane ring carrying two methyl groups, and a 2-aminoethyl side chain. Each part has a role beyond textbook structural representation. The 1,3-dioxane core makes it suitable for use as a protected sugar or sugar mimic, which has implications in carbohydrate chemistry, glycodiversification, and the preparation of peptidomimetic or glycopeptide candidates. The aminoethyl substituent opens doors for downstream functionalization, whether building secondary or tertiary amines, making linkages to solid supports, or coupling in multistep syntheses. We have seen medicinal chemists lean into this scaffold precisely for these modular opportunities.

    Our batches typically follow a rigorous synthetic route that begins with the enantioselective formation of the dioxane core. Achieving and verifying the 4R,6R configuration relies on closely monitoring reaction temperatures and using well-established chiral catalysts. Even subtle deviations can change the enantiomeric ratio, which is critical for both the compound’s physical properties and its ultimate biological utility. We back our process with routine chiral HPLC and NMR validation, supporting the strict demands from clients working in regulated environments. Documenting every run has become a habit, not just to comply with best practices, but to provide peace of mind for partners advancing IND-enabling studies or producing reference standards.

    Our standard production scale ranges from 10 grams to kilogram lots, depending on project demands. Maintaining purity—typically verified by HPLC and NMR—serves both researchers screening for hits and scale-up operations heading toward preclinical batches. Our chemists have observed that even trace impurities, often originating from precursor reagents or incomplete deprotection steps, can complicate downstream purification. A deep understanding of these pitfalls, gained through thousands of analytical runs and troubleshooting sessions, informs both our cleaning protocols and our guideline recommendations for customers. We do not simply report purity as a figure; before each delivery, our technical team reviews chromatograms and spectral data to flag and resolve abnormalities.

    Some users have chosen this acetate derivative in preference to analogous benzyl or methyl esters. The tert-butyl group offers selective removability under mildly acidic conditions, typically using trifluoroacetic acid. This contrasts with benzyl derivatives, which require harsher hydrogenolysis conditions that may not be compatible with other sensitive functional groups. Dioxane-based scaffolds incorporating methyl groups at the 2,2-positions increase conformational rigidity, reducing byproduct formation in cyclizations or elaboration steps. We have fielded requests for similar structures containing alternate alkyl or protecting groups, but the unique combination of the tert-butyl acetate and dioxane core provides both reactivity and selective deprotection options that facilitate flexibility for downstream chemistries.

    In method development, reproducibility often hinges on the reliability of starting materials. Our synthesis has optimized drying and handling protocols for tert-butyl 2-((4R,6R)-6-(2-aminoethyl)-2,2-dimethyl-1,3-dioxan-4-yl) acetate, giving users improved batch-to-batch consistency. Moisture remains one of the main contaminants, impacting yields in follow-on steps such as amide couplings or reductive aminations, especially when using sensitive carbodiimide activators or borohydrides. Each lot comes with a water content analysis and full batch history, drawing from our own experiences as researchers frustrated with inconsistent suppliers.

    Researchers targeting complex glycopeptides or sialylated compounds often seek starting materials that balance reactivity with stability. Sugar mimics based on dioxane rings, as seen in this molecule, sidestep some of the instability that hinders furanose and pyranose analogues—particularly under basic or high-temperature conditions. Our internal studies tracking decomposition curves have demonstrated that tert-butyl acetate derivatives hold up well under mild to moderately acidic conditions, a result echoed by external feedback from clients scaling up oligosaccharide linkages and conjugates. Our production schedules build in routine stability testing, with accelerated-aging studies confirming at least a 12-month shelf life under recommended storage.

    Sourcing remains a challenge for synthetic chemists searching for advanced intermediates. Our experience in developing and controlling the supply of chiral dioxane scaffolds has taught the team to screen all incoming raw materials not only for purity but also for trace metal and solvent residue. The cost of missing these traces—chloride, sulfate, or palladium—often emerges not at the QC bench but midway through a multi-step transformation where intractable byproducts form. We run ICP-MS scans not out of compulsion, but from lessons learned in failed runs and the feedback loop between manufacturing teams and analytical support.

    With regards to the downstream application, one of the recurring feedback themes we hear relates to the ease with which the amino group in the 2-aminoethyl side chain can be derivatized. Pharmaceutical chemists have used this functionality as a nucleophile in a broad range of alkylation and acylation steps, sometimes followed by further protection or cyclization. Bioconjugation researchers have used the same handle to attach dyes and probes, building functionalized carbohydrate-based sensors or linkers. The controlled release of the tert-butyl group under cleavage conditions ensures that intermediate forms remain intact until the final or penultimate step.

    We have made concerted efforts to support teams facing challenges in scale-up, offering advice on solvent recapture, drying, and safe handling. Our own scale-up campaigns have exposed process hazards such as exothermic deprotections or dioxane ring opening. Our process chemists document mitigation steps—such as staged acid addition or in-line quenching—and these shared experiences end up helping users skip common pitfalls that cost both time and starting material.

    In consulting with customers developing APIs and new materials, questions inevitably emerge about the difference between our tert-butyl acetate derivative and functionally similar precursors. The tert-butyl ester offers a clear path for selective hydrolysis without the risk of overcleavage seen with more labile methyl esters or ethyl esters. On the dioxane ring, two adjacent methyl substitutions set our product apart from unsubstituted or mono-methylated analogues—not just changing conformational rigidity, but also affecting solvent compatibility and crystallization. Formulators developing solid dosage forms have commented that this variant tends to crystallize more cleanly, thanks to the packing effect of the methyl groups, improving both handling and purity after scale-up.

    Technical teams interested in analytical methods have noted that our material provides defined signatures in both NMR and mass spectrometry, aiding in downstream structure elucidation work. The tert-butyl acetate and dimethyl dioxane groups give characteristic peaks for carbon and proton environments, making impurity identification faster and reducing ambiguities. The high diagnostic value of these spectra streamlines method validation, an advantage often overlooked when rapid progress through late-stage development matters.

    We monitor feedback from researchers working in both discovery and process development labs. One trend stands out: projects often request customizations—alternate salts, additional purification passes, unique storage containers, or even dedicated synthetic campaigns for closely related compounds. Our experience allows us to adapt processes accordingly while retaining rigorous documentation standards. In large part, this flows from our history as a manufacturer rather than a trader. Each process troubleshooting note, each deviation report, and each customer call logs new lessons for future runs. This boils down to more reliable supply and tailored support beyond just the technical data.

    Down the chain, shorter timelines and regulatory expectations raise the bar for intermediate quality. Our in-house regulatory team keeps pace with updates to ICH, REACH, and U.S. Drug Master File processes relevant to chiral intermediates, and we maintain up-to-date traceability records for each batch. Auditing, both internal and external, reinforces our process controls. We incorporate findings from audits directly into SOPs, closing the gap between day-to-day lab work and best practices in manufacturing. Because our reputation hinges on real, verifiable product quality, our chemists check every batch against cumulative experience.

    Supply integrity extends beyond material specifications. We see fluctuations in precursor availability, unexpected changes in supplier certifications, and shifts in environmental guidelines for chemical emissions. As a company running our own reactor bays and analytic suites, we face these challenges directly. Adaptations include qualifying multiple sources, keeping six-month rolling stocks of critical raw inputs, and building relationships with logistics partners who understand the unique requirements of specialty chemicals. Buffer stocks and redundant equipment prevent many of the common delays that disrupt project milestones.

    Our facilities have faced the same regulatory and energy cost pressures as the rest of the industry. Optimizing synthesis steps for waste minimization, energy efficiency, and solvent recovery became a priority as soon as production surpassed R&D scale. Our process team now reviews every route for step economy, switching to continuous workflow where possible and implementing closed-loop solvent recapture. These efforts reduce operational costs and help us align with the growing environmental demands placed on specialty chemical manufacturers.

    We are well aware that documentation, transparency and open technical dialogue set reliable manufacturers apart from traders or resellers. Each batch’s record includes not just the certificate of analysis, but also data on process changes, analytical rechecks, and detailed storage recommendations. Our technical support team fields questions from process validation teams, often walking clients step-by-step through purification, deprotection, or crystallization protocols. In many cases, this reduces cycle times and helps keep fast-moving development projects on track.

    Handling and packaging play a larger role than many realize until a batch arrives clumped, or static-prone, or smelling faintly of decomposition. Through hands-on troubleshooting, we have learned to select packaging tailored to the compound’s hydrophobic and hygroscopic balance. Moisture-resistant, antistatic-lined bottles—sealed under inert atmosphere—are now standard for this acetate derivative. Low-headspace packing reduces the risk of atmospheric moisture ingress in transit, a frequent culprit of failed reactions downstream.

    Partnership goes beyond product delivery. Our lab and plant teams offer up technical support for those examining alternate synthetic routes, reworking failed reactions, or optimizing isolation protocols. The knowledge base that comes from running and analyzing the same transformations on multiple scales provides actionable, experience-based advice. Collaboration on yield and troubleshooting, built on years processing the same families of dioxane-based amino acid derivatives, moves projects from troubleshooting to solution discovery with less resource waste.

    Product quality stands not just on physical specification, but on the cumulative knowledge built from every synthesis run, every analytical review, and every delivery. With tert-butyl 2-((4R,6R)-6-(2-aminoethyl)-2,2-dimethyl-1,3-dioxan-4-yl) acetate, our commitment covers the full process: from route design, through analytical vigilance, to hands-on customer support and supply management. Our product aims not merely to meet specification—a goal anyone can state—but to empower chemists at the bench and in the plant, drawing on lessons learned directly from the manufacture of specialty chiral intermediates.

    This acetate derivative does not exist as just a collection of atoms or regulatory codes. It represents the interface between chemical theory and practical application, drawing on years of synthetic know-how, analytical diligence, supply chain stability, and a direct feedback loop with users navigating the challenges of modern research and manufacturing. Every gram tells a story of lessons learned in pursuit of process control, reproducible results, and efficient project delivery.

    We continue to refine our procedures and invest in our infrastructure, precisely because the needs of chemists and technologists evolve. As our partners advance in glycoscience, peptide synthesis, or medicinal chemistry, our team stands ready to share experience, troubleshoot new challenges, and provide a product grounded in practice, not just paperwork.